7084
E. Manzo et al. / Tetrahedron Letters 53 (2012) 7083–7084
NCO
O
NH
H
N-ethylmorpholine-DMF
RO
N
H
NH2
N
0°C / 1h - r.t. / 5h
3, R=H
NH
3a, R=Me
O
RO
1, R=H, 11%
NH
NH2
H
2, R=Me, 10%
MeOOC
N
H
2 HCl
NH2
Figure 2. Coupling reaction to get parazoanthine A (1) and the O-Me analog (2).
NaN3-Cl3CCN
COOH
CON3
NCO
PPh3
Toluene
68°C/overnight
CH3CN
r.t / 2h
RO
RO
RO
3, R=H 78%
4, R=H
5, R=H 81%
5a, R=Me 78%
3a, R=Me 79%
4a, R=Me
Figure 3. Preparation of synthetic isocyanate precursors of parazoanthine A and its O-Me-analog.
Compounds 1 and 2 were obtained in the best yield of 11% and 10%,
respectively, by carrying out the reaction at rt, in DMF, and with
1.2 equiv of N-ethylmorpholine. The C-5 chirality was preserved
by the coupling reaction.
The spectral data of synthetic parazoanthine A (1) were identi-
cal to those of natural compound.1 O-Me parazoanthine A (2)
showed 1H and 13C NMR spectroscopic data similar to parazoan-
thine A differing only in the presence of the methoxy group on
the aromatic ring instead of the hydroxyl function (see Supplemen-
tary Supporting Information).
References and notes
1. Cachet, N.; Genta-Jouve, G.; Regalado, E. L.; Mokrini, R.; Amade, P.; Culioli, G.;
Thomas, O. P. J. Nat. Prod. 2009, 72, 1612–1615.
2. Thenmozhiyal, J. C.; Wong, P. T. H.; Chui, W. K. J. Med. Chem. 2004, 47, 1527–
1535.
3. (a) Bazil, C. W.; Pedley, T. A. Annu. Rev. Med. 1998, 49, 135–162; (b) Luer, M. S.
Neurol. Res. 1998, 20, 178–182.
4. (a) Matsukura, M.; Daiku, Y.; Ueda, K.; Tanaka, S.; Igarashi, T.; Minami, N. Chem.
Phar. Bull. 1992, 40, 1823–1827; (b) Knabe, J.; Baldauf, J.; Ahlhelm, A. Pharmazie
1997, 52, 912–919.
5. Somsak, L.; Kovacs, L.; Toth, M.; Osz, E.; Szilagyi, L.; Gyorgy-deak, Z.; Dinya, Z.;
Docsa, T.; Toth, B.; Gergely, P. J. Med. Chem. 2001, 44, 2843–2848.
6. (a) Moloney, G. P.; Robertson, A. D.; Martin, G. R.; MacLennan, S.; Mathews, N.;
Dosworth, S.; Sang, P. Y.; Knight, C.; Glen, R. J. Med. Chem. 1997, 40, 2347–2362;
(b) Moloney, G. P.; Martin, G. R.; Mathews, N.; Milne, A.; Hobbs, H.; Dosworth,
S.; Sang, P. Y.; Knight, C.; Williams, M.; Maxwell, M.; Glen, R. J. Med. Chem. 1999,
42, 2504–2526.
This is the first synthetic strategy of a member of parazoanthine
class that could open the way for the preparation of other natural
and not natural analogs.
Acknowledgments
7. Jansen, M.; Potschka, H.; Brandt, C.; Loscher, W.; Dannhardt, G. J. Med. Chem.
2003, 46, 64–73.
8. Last-Barney, K.; Davidson, W.; Cardozo, M.; Frye, L. L.; Grygon, C. A.; Hopkins, J.
L.; Jeanfavre, D. D.; Pav, S.; Qian, C.; Stevenson, J. M.; Tong, L.; Zindel, R.; Kelly,
T. A. J. Am. Chem. Soc. 2001, 123, 5643–5650.
9. A sample of P. axinellae, collected off greek coasts, was chemically analysed, in
the frame of a collaborative project with Professor V. Roussis (University of
Athens). The results of this study will be published elsewhere.
10. Stilz, H. U.; Guba, W.; Jablonka, B.; Just, M.; Klingler, O.; Konig, W.; Wehner, V.;
Zoller, G. J. Med. Chem. 2001, 44, 1158–1176.
The authors thank Mr. Alessandro Esposito of ICB-NMR service,
M. Zampa of ‘Servizio di Spettrometria di Massa’ for HRESIMS, and
C. Iodice for spectrophotometric measurements. This work was
partially funded by PRIN-MIUR 2009 Project ‘Prodotti naturali da
molluschi opistobranchi: identificazione di nuovi lead compounds
per lo sviluppo di farmaci antitumorali’.
11. Kim, J. G.; Jang, D. O. Synlett 2008, 2072–2074.
12. Marinescu, L.; Thinggaard, J.; Thomsen, I. B.; Bols, M. J. Org. Chem. 2003, 68,
9453–9455.
Supplementary data
Supplementary data associated with this article can be found,